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Sequential Modification of NEMO/IKK by SUMO-1
and Ubiquitin Mediates NF-B Activation
by Genotoxic Stress
including inflammatory reactions, immune responses,
and apoptosis (Ghosh and Karin, 2002; Li and Verma,
2002). NF-B is normally kept inactive in the cytoplasm
of unstimulated cells by its inhibitor proteins, such as
IB and IB. Consequently, the release of NF-B from
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the IB proteins is a prerequisite for NF-B translocationUniversity of Wisconsin-Madison
into the nucleus to regulate gene transcription. Interest-301 SMI
ingly, inactive NF-B proteins associated with IB shut-1300 University Avenue
tle between the cytoplasm and the nucleus, but IBMadison, Wisconsin 53706
cytoplasmically sequesters inactive NF-B without nu-
cleocytoplasmic shuttling (Huang and Miyamoto, 2001;
Malek et al., 2001; Tam and Sen, 2001). Nevertheless,
enucleation experiments have demonstrated that theSummary
release of active NF-B by extracellular stimuli can be
accomplished solely within the cytoplasm (Baeuerle andThe transcription factor NF-B is critical for setting
Baltimore, 1988; Devary et al., 1992; Huang et al., 2000b).the cellular sensitivities to apoptotic stimuli, including
In contrast, nuclear events are required for activation ofDNA damaging anticancer agents. Central to NF-B
NF-B by certain genotoxic agents (Huang et al., 2000a).signaling pathways is NEMO/IKK, the regulatory sub-
Therefore, DNA damage-dependent activation of NF-Bunit of the cytoplasmic IB kinase (IKK) complex. While
serves as an attractive paradigm to study molecularNF-B activation by genotoxic stress provides an at-
mechanisms involved in nuclear-to-cytoplasmic signaltractive paradigm for nuclear-to-cytoplasmic signal-
transduction pathways.ing pathways, the mechanism by which nuclear DNA
Central to the activation of NF-B by extracellulardamage modulates NEMO to activate cytoplasmic IKK
stimuli is the IB kinase (IKK) complex that is composedremains unknown. Here, we show that genotoxic
of two catalytic subunits IKK/1 and IKK/2, and a regu-stress causes nuclear localization of IKK-unbound
latory subunit NF-B essential modulator (NEMO/IKK)NEMO via site-specific SUMO-1 attachment. Surpris-
(Ghosh and Karin, 2002). Signaling pathways convergeingly, this sumoylation step is ATM-independent, but
onto and activate the IKK complex, leading to site-spe-nuclear localization allows subsequent ATM-depen-
cific phosphorylation of IB and its degradation by thedent ubiquitylation of NEMO to ultimately activate IKK
ubiquitin-proteasome pathway allowing liberation ofin the cytoplasm. Thus, genotoxic stress induces two
NF-B. While transient overexpression of the catalyticindependent signaling pathways, SUMO-1 modifica-
subunits alone is sufficient to activate NF-B, their phys-tion and ATM activation, which work in concert to
iological activation requires the presence of NEMO insequentially cause nuclear targeting and ubiquityla-
the complex. The importance of NEMO in the regulationtion of free NEMO to permit the NF-B survival path-
of IKK and NF-B activity has been demonstrated inway. These SUMO and ubiquitin modification path-
a NEMO-deficient mouse 1.3E2 pre-B cell model andways may serve as anticancer drug targets.
mouse knockout experiments, in which the complete
loss of NF-B activation is shown by various stimuliIntroduction
despite the presence of the catalytic subunits (Li and
Verma, 2002). Moreover, two types of human disorders
Activation of signal transduction pathways by extracel-
have been genetically linked to mutations occurring in
lular stimuli is frequently initiated by the interaction of
the NEMO gene. Non-sense mutations in the NEMO
specific ligands with their cognate cell surface recep- gene are associated with incontinentia pigmenti (Smahi
tors. A variety of mechanisms have been found to trans- et al., 2000), whereas point mutations in the encoded
mit these interactions through the cytoplasm into the C-terminal zinc finger (ZF) domain affecting only a sub-
nucleus to alter the gene expression program via the set of NF-B activation pathways are found in patients
activation of preexisting transcription factors (Hunter, with anhidrotic ectodermal dysplasia in conjunction with
2000; Karin and Hunter, 1995). However, very little is immunodeficiency syndromes (Doffinger et al., 2001;
known regarding signaling pathways that are initiated Jain et al., 2001). Since NEMO is predicted to be com-
in the nucleus and transferred to the cytoplasm—the posed of multiple distinct domains (Ghosh and Karin,
“nuclear-to-cytoplasmic” signaling pathways. 2002), these different modules may serve as a signal
The NF-B/Rel family of transcription factors has been integrating platform to link a wide range of NF-B induc-
intensively studied as an important model system for ing signals to the activation of the IKK catalytic subunits.
how extracellular stimuli, such as tumor necrosis factor NEMO was shown to recruit IKK to the T cell receptor
 (TNF), interleukin-1, or bacterial endotoxin (LPS), (Weil et al., 2003) and the Tax protein of the HTLV-1
cause the activation of latent transcription factors via directly interacts with NEMO to activate IKK and NF-B
signal transduction cascades. NF-B regulates the ex- (Sun and Ballard, 1999). The use of a NEMO binding
pression of genes critical for multiple biological processes, domain (NBD) peptide derived from IKK also indicated
that the association between the catalytic subunits and
NEMO may not be static in vivo (May et al., 2000). How-*Correspondence: smiyamot@wisc.edu
Cell
566
ever, the significance of IKK-NEMO association and dis- dependent ubiquitylation of NEMO. Since IKK activated
sociation in signal-induced activation of IKK remains un- by DNA damaging agents is ultimately present in the
clear. cytoplasm in association with NEMO, our findings sug-
Like the membrane receptor signaling pathways, gest that NEMO nuclear transition and modification that
those initiated by DNA damaging agents also require are coordinated by SUMO-1 and ATM permit the NF-B
NEMO to activate IKK and NF-B (Huang et al., 2000a; genotoxic stress pathway.
Li and Karin, 1998). Moreover, the ZF domain is essential
for DNA damage activation of NF-B, but it is largely Results
dispensable for LPS signaling (Huang et al., 2002). Muta-
tions that disrupt the ZF were also shown to affect cer- DNA Damaging Agents Cause SUMO-1
tain types of TNF receptor superfamily signaling path- Modification of NEMO in a ZF-Dependent Manner
ways (Jain et al., 2001; Makris et al., 2002). It is possible We previously identified the C-terminal ZF of NEMO
that the ZF may recruit IKK to the upstream signaling to be essential for NF-B activation by VP16 and CPT
components induced by DNA damage or it may regulate (Huang et al., 2002). To probe into the role of this domain,
specific NEMO modifications to permit IKK activation. we looked for modifications of NEMO that were induced
However, the mechanistic role of the NEMO ZF in the in a ZF-dependent fashion. Stimulation of NEMO-defi-
NF-B genotoxic stress pathway is currently unknown. cient 1.3E2 cells stably reconstituted with Myc-epitope
Posttranslational modification of proteins by the small tagged wild-type (WT) NEMO protein at physiological
ubiquitin-like modifier (SUMO) emerged as an important levels (Huang et al., 2002) with VP16 caused the appear-
regulatory mechanism (Muller et al., 2001; Pickart, 2001). ance of a slower migrating band that could only be
Presently, there are two models describing the general revealed when cell extracts were prepared by immedi-
functions of SUMO modification; it may alter protein ately boiling cell suspensions in 1% SDS (Figure 1A).
stability by competing with ubiquitylation (Desterro et Protein modifications with an increase of 20 kDa can
al., 1998) or modulate protein-protein interactions to be associated with SUMO conjugation (Mahajan et al.,
alter subcellular localization (Mahajan et al., 1997; Ma- 1997; Matunis et al., 1996). This protein band was de-
tunis et al., 1996; Muller et al., 1998). Although the Ran tected by antibodies against Myc-NEMO and SUMO-1
GTPase-activating protein (RanGAP1), a component of following denaturation and immunoprecipitation (Figure
the nuclear import machinery, was the first described 1A, top images). Thus, it represented covalently SUMO-1
SUMO substrate (Mahajan et al., 1997; Matunis et al., conjugated NEMO. When similarly expressed ZF mutant
1996), it remains one of few cytosolic substrates of C417R NEMO was analyzed, we failed to detect any
SUMO. Most sumoylated proteins are nuclear (Muller et sumoylation (Figure 1A, top images). Thus, intact ZF was
al., 2001; Seeler and Dejean, 2003). Moreover, SUMO-1 required for this SUMO-1 conjugation. VP16-induced
activating and conjugating enzymes are also found pre- sumoylation of NEMO was also seen in HEK293 cells
dominantly in the nucleus (Rodriguez et al., 2001). A (Figure 1B, lanes 3–5), demonstrating that it was not a
recent study has linked SUMO-1 modification of prolifer- 1.3E2 cell line specific event. SUMO-1 modification of
ating cell nuclear antigen (PCNA) as a component of a NEMO was also evident with CPT, but not with TNF
cellular decision between DNA replication and postrepli- (Figure 1B) or LPS (Figure 1A). Finally, SUMO-1 modifica-
cative DNA repair following DNA damage induction tion was also seen with the endogenous NEMO (Figure
(Hoege et al., 2002). 1C). These results together indicated that DNA-damag-
Ataxia telangiectasia mutant (ATM) protein is a critical ing agents induced signal-selective SUMO-1 conjuga-
signal-transducing kinase for mediating certain forms
tion of NEMO in a manner dependent on the ZF domain.
of DNA damage (Abraham, 2001; Kastan and Lim, 2000).
DNA double-strand breaks (DSBs) induced by radiation
Disruption of the Sumoylation Sites on NEMOor certain anticancer agents, such as topoisomerase I
Abrogates DNA Damage-Dependentinhibitor camptothecin (CPT) and topoisomerase II in-
IKK Activationhibitor etoposide (VP16), have been shown to activate
Two lysine residues of NEMO, K277 and K309, conformATM. While the mechanisms involved in ATM activation
to the proposed consensus motif KxD/E (where  isare beginning to be elucidated (Bakkenist and Kastan,
a hydrophobic residue and x represents any residue)2003), there are many molecular players that mediate
(Rodriguez et al., 2001) (Figure 2A). To determine if oneATM-dependent cell cycle checkpoint and DNA repair
of these lysines represented the in vivo SUMO-1 modifi-regulations. These include CHK1 and CHK2 kinases,
cation site, single (K277A and K309A) and double lysineBRCA1, NBS1, and p53, among others (Kastan and Lim,
to alanine (DK-mut) substitution mutants were con-2000; Zhou and Elledge, 2000). ATM has also been impli-
structed and examined as above. Although NEMO su-cated in the regulation of DNA damage activation of NF-
moylation was partially inhibited by single mutationsB (Li et al., 2001). It is entirely unknown, however, how
(data not shown), DK-mut was not SUMO-1 modifiedthe principally nuclear ATM kinase causes the activation
(Figure 2B). While LPS was capable of inducing NEMO-of the cytoplasmic IKK complex to mediate NF-B acti-
associated IKK kinase activity in cells expressing eithervation.
WT or DK-mut NEMO, VP16, or CPT could not activateIn the present study, we have examined the role of
IKK with DK-mut NEMO (Figure 2C). Accordingly, neitherthe NEMO ZF domain in the regulation of IKK activation
IB degradation nor NF-B DNA binding activity wasby genotoxic stress. We provide evidence that these
induced in the DK-mut cells upon stimulation with DNAstresses cause nuclear translocation of free NEMO via
damaging agents (Figure 2E). Single lysine mutantssite-specific SUMO-1 modification in a ZF-dependent
showed only mild inhibitory effects (Figure 2D), sug-manner. We provide further evidence that nuclear local-
ization of NEMO is required to permit subsequent ATM- gesting that the other intact lysine compensates for the
Sumoylation and ATM Regulation of NF-B Signaling
567
Figure 1. ZF-Dependent SUMO-1 Modification of NEMO
(A) NEMO-deficient 1.3E2 cells stably reconstituted with either Myc-tagged NEMO WT or a ZF point mutant (C417R) were left untreated or
treated with VP16 (10 M) for 1 hr. Protein extracts were immunoprecipitated with either SUMO-1 or Myc antibodies and analyzed by Western
blotting with either Myc or SUMO-1 antibodies.
(B) HEK293 cells stably expressing Myc-tagged NEMO were either transfected with vector control (lanes 1 and 7) or HA-SUMO-1 plasmid.
48 hr after transfection, the cells were left untreated or treated with VP16 as in (A), or CPT (10 M) or TNF (10 ng/ml) for the indicated times.
Protein extracts were immunoprecipitated with Myc antibody and immunoblotted with either HA or Myc antibodies.
(C) HEK293 cells untreated or treated with VP16 as above for 1 hr were then processed as above and immunoprecipitated with the NEMO
antibody and immunoblotted with either SUMO-1 or NEMO antibody.
mutated lysine residue. Similar observations were made modulation of subcellular localization of WT and DK-
mut proteins was next examined. Both WT and DK-mutwhen two lysines were substituted with arginines (data
not shown). proteins were predominantly localized in the cytoplasm
of unstimulated cells (Figures 3A and 3B, upper and
lower images). Surprisingly, many cells treated withSUMO-1-Modified NEMO Accumulates
in the Nucleus in Response to Genotoxic Stress VP16 showed evidence for nuclear staining of the WT
NEMO proteins (Figures 3A and 3B). DK-mut NEMO re-SUMO-1 modification may be associated with altered
protein stability, but DNA damaging agents did not mained cytoplasmic (Figures 3A and 3B), correlating
with its lack of sumoylation (Figures 2B). LPS stimulationchange the levels of NEMO (Figure 1C and others). Thus,
Cell
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Figure 2. Lysines 277 and 309 of NEMO Are Critical for SUMO-1 Modification and DNA Damage-Induced IKK and NF-B Activation
(A) Schematic representation of NEMO and SUMO-1 modification sites (K277 and K309). Two coiled coil regions (CC1, CC2), leucine zipper
(LZ), and ZF domains are shown.
(B) The parental or 1.3E2 cells complemented with Myc-tagged WT, DK-mut, and C417R NEMO were either left untreated or treated with
VP16 (10 M, 60 min), and used for cell extracts preparation, immunoprecipitation with Myc antibody, and analysis by Western blotting with
either SUMO-1 or Myc antibody.
(C) 1.3E2 cells stably reconstituted with either Myc-tagged WT or DK-mut NEMO were left untreated or treated with LPS (20 g/ml, 30 min),
CPT (10 M, 60 min), or VP16 (10 M, 60 min). Protein extracts were immunoprecipitated with Myc antibody and subjected to a kinase assay.
Immunoblotting with IKK or GST antibody was performed with the kinase reactions as a loading control. Fold IB phosphorylation induction
was measured using ImageQuant following exposure to Phosphorimager.
(D) 1.3E2 cells stably reconstituted with either Myc-tagged NEMO WT or single lysine mutants (K277A and K309A) were untreated or treated
with LPS (20 g/ml, 60 min), CPT (10 M, 120 min), or VP16 (10 M, 120 min). Protein extracts were examined with EMSA and Western blotting
using IB, Myc, and p65 antibodies. Fold induction of NF-B DNA binding activity was measured as above.
(E) DK-mut cells were treated and analyzed as in (A).
also did not alter the localization of these proteins (Fig- NEMO became cytoplasmic (Figure 4B, images 4 and
5). Similarly, excess SUMO-NEMO did not change theures 3A and 3B). Biochemical fractionation also sup-
ported nuclear accumulation of NEMO (Figure 3C). How- cytoplasmic localization of IKK (Figure 4B, image 6).
These observations implicated that only the IKK-ever, since SUMO-1 modification was labile without
boiling cell samples, we were unable to detect sumoy- unbound form of NEMO could accumulate in the nucleus
upon SUMO-1 modification. To directly determine whetherlated NEMO in these fractionation experiments that pre-
cluded prior boiling of cell samples in SDS. There was IKK association is dispensable for sumoylation, we dis-
rupted this association with a cell-permeable NBD pep-no detectable nuclear localization of the IKK, unlike
when cells were stimulated with certain cytokines (Anest tide (Figure 4C, compare lanes 12 and 13) and found that
there was no impact on NEMO SUMO-1 modificationet al., 2003; Yamamoto et al., 2003; also see below).
Expression constructs that tethered SUMO-1 to the (compare lanes 10 and 11). However, inhibition of NF-
B activation by DNA-damaging agents (Figure 4C,N terminus of NEMO (Figure 4A) revealed that the WT,
C417R, and DK-mut NEMO proteins displayed largely compare lanes 6–8) indicated that activation of NF-B
ultimately required the association of NEMO with IKKcytoplasmic localization (Figure 4B, 1-3, upper images),
but SUMO-1 attachment resulted in their nuclear tar- catalytic subunits (also see below).
SUMO-1 attachment to NEMO did not induce consti-geting (Figure 4B, compare images 1-3, upper and lower
images). Thus, covalent modification by SUMO-1 could tutive NF-B activation when stably expressed in 1.3E2
(Figure 4D, lanes 1 and 5). LPS- and DNA damage-explain the nuclear localization of NEMO observed fol-
lowing DNA damage induction. Interestingly, when ex- induced NF-B activation was efficient in these cells
(Figure 4D), indicating that SUMO did not impair thecess IKK catalytic subunit was coexpressed, SUMO-
Sumoylation and ATM Regulation of NF-B Signaling
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Figure 3. NEMO Localization to the Nucleus
by Genotoxic Stress Depends on Intact
Lys277 and 309
(A) Immunofluorescence of the 1.3E2 parental
and those stably reconstituted with either
Myc-tagged WT or DK-mut NEMO. Cells were
untreated or treated with LPS (20 g/ml, 30
min) or VP16 (10 M, 90 min) and immuno-
stained with the Myc antibody. Nuclei were
visualized by Hoechst staining.
(B) Cells were treated as in (A) except the
cells were costained with both p65 (green) or
Myc (red) antibody and Hoechst dye (blue).
(C) HEK293 cells stably expressing Myc-
NEMO were untreated or treated with VP16 at
the indicated times. Cytoplasmic and nuclear
extracts were generated and equivalent
amounts of proteins were loaded on SDS-
PAGE. Western blot analysis was done using
the indicated antibodies. -Tubulin and Ran
GTPase were shown for cytoplasmic and nu-
clear controls, respectively.
function of NEMO. Importantly, NF-B signaling defects to molecular weights of one or two ubiquitin molecules.
Time course experiments showed the presence of atassociated with ZF deficiency was compensated for by
the SUMO-1 attachment (Figure 4E, compare lanes 4 least two major modification bands—slower migrating
band transiently peaking around 45 to 60 min and theand 9). Thus, SUMO-1 modification is both necessary
and sufficient to overcome the NF-B activation defects other faster migrating one that became apparent around
60–90 min and remained detectable up to 120 min (Fig-associated with mutations in the ZF domain of NEMO.
However, unlike the ZF mutant, DK-mut deficiencies ure 5A, upper image). The slower migrating band was
detectable by SUMO-1 antibody (Figure 5A, middle im-were not complemented by SUMO-1 (Figure 4E, com-
pare lanes 12 and 15). These results suggested that age), whereas ubiquitin antibody detected the other (Fig-
SUMO-1 modification of NEMO was necessary but in- ure 5A, lower image). Even though Myc antibody de-
sufficient for DNA damage-induced NF-B activation. tected the faster migrating band appearing at 45 min
and peaking around 90 min, ubiquitin antibody only effi-
ciently detected them at 90 min and somewhat less atLysines 277/309 of NEMO Are Necessary
120 min time points. This difference in detection by Mycfor Subsequent Modification by Ubiquitin
and ubiquitin antibodies is likely due to the inefficientFollowing DNA Damage Induction
detection of ubiquitylated NEMO by ubiquitin antibody.We have on occasion noted that there were additional
When similar time course samples were analyzed byfaint NEMO bands that appeared below the SUMO-1
EMSA, NF-B activation was detectable at 60 min timemodified band upon DNA damage induction, depending
and steadily increased to a peak at 120 min (Figure 5A,on time points analyzed (e.g., Figure 2B, asterisk). The
size increase was on the order of 8–16 kDa, equivalent bottom image). This “peak” detection does not imply
Cell
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Figure 4. SUMO-1 Targets NEMO to the Nucleus
(A) Schematic diagrams of WT and mutant NEMO constructs N terminally fused to SUMO-1 lacking the C-terminal Gly-Gly residues. The
SUMO-NEMO fusion constructs are HA tagged, and nonfusion NEMO constructs are Myc-tagged.
(B) Cos7 cells transfected with the indicated constructs were analyzed by immunofluorescence with Myc (pictures 1–3, upper images; and
picture 4, upper and lower images), HA (pictures 1–3, lower images; and picture 5, upper and lower images), or Flag (picture 6) antibody. For
lower images of pictures 4 and 5, four times the amount of the Flag-IKK construct was transfected in comparison to WT or SUMO-WT
constructs. In picture 6, four times the amount of SUMO-WT construct was transfected in comparison to Flag-IKK.
(C) 1.3E2 cells stably reconstituted with Myc-tagged NEMO WT were pretreated with increasing concentration of cell-permeable NBD peptide
and then stimulated with either TNF (10 g/ml, 60 min) or VP16 (10 m, 60 min) as in Figure 1B. Samples were then analyzed by EMSA or
immunoprecipitation as indicated. 20 M of NBD peptide was used for the IP samples. A low-level basal sumoylation of NEMO could be seen
(lane 9), but the reason for this is unknown.
(D) 1.3E2 cells stably expressing Myc-NEMO-WT or SUMO-NEMO-WT were treated with LPS (20 g/ml, 30 min) or CPT (10 m, 120 min) and
VP16 (10 m, 120 min). Protein extracts were analyzed with EMSA and Western blot.
(E) 1.3E2 cells stably expressing WT, C417R, and DK-mut NEMO or corresponding SUMO-fusion constructs were left untreated or treated
with LPS (30 min) or VP16 (120 min) and the protein extracts were analyzed by EMSA and immunoblotting with either HA or Myc antibody.
the absence of modification leading to activation earlier damage induction. Furthermore, consistent with the no-
tion that transient sumoylation is the major rate-limitingthan the peak time, as evidenced from the mild activa-
tion of NF-B within 60 min. Nevertheless, these peak step for NF-B activation, constitutive presence of
SUMO-NEMO protein permitted faster and longer acti-time points are consistent with the sequential events of
sumoylation, ubiquitylation, and finally NF-B activation. vation kinetics compared to WT NEMO (Figure 5C;
see Discussion).Since direct conjugation of SUMO-1 to NEMO com-
pensated for the ZF deficiency but failed to do so for
the DK mutant (Figure 4E), we next evaluated whether ATM Is Dispensable for Sumoylation but Essential
for Ubiquitylation of NEMOthese lysine residues were also required for ubiquityla-
tion. Induction of slower migrating bands could be Since DNA damaging conditions, especially those that
induce DSBs, activate ATM and its related kinase ATRequally detected on both the SUMO-1-fused WT and ZF
mutant of NEMO (Figure 5B, lanes 2–3 and 5–6). These (Abraham, 2001), we next examined whether sumoyla-
tion and ubiquitylation of NEMO were regulated by theseslower bands could be detected by the ubiquitin anti-
body (data not shown), indicating that an intact ZF was DNA damage-signaling kinases. We first evaluated the
requirements of these kinases in NF-B activation bynot required for this modification. In contrast, ubiquitin
conjugation was not seen with the SUMO-1 conjugated VP16 treatment by employing the small interfering RNA
strategy (siRNA) to knockdown their expression levels.DK mutant (lanes 8–9). Thus, while SUMO-1 permitted
nuclear accumulation of NEMO, lysine 277/309 were Both siRNAs against ATM and ATR effectively and spe-
cifically reduced the expression of corresponding ki-further required for subsequent ubiquitylation upon DNA
Sumoylation and ATM Regulation of NF-B Signaling
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Figure 5. Sumoylation of NEMO Precedes Ubiquitylation and NF-B Activation Following Genotoxic Stress
(A) 1.3E2 cells stably expressing Myc-NEMO-WT were treated with or without VP16 (10 m) for the indicated amount of time and used for
immunoprecipitation experiments to detect ubiquitylated and sumoylated NEMO, using the indicated antibodies for Western blot analysis.
Arrows in the upper image point to corresponding bands detected in the middle and lower images. The similar time course samples were
prepared for EMSA analysis to detect NF-B activation.
(B) 1.3E2 cells expressing SUMO-WT, SUMO-C417R, or SUMO-DK-mut were treated with VP16 (10 m) for the following time intervals and
processed for immunoprecipitation followed by Western blot analysis using HA antibody.
(C) Myc-NEMO-WT and SUMO-NEMO-WT cells were treated with VP16 (10 M) for indicated times and analyzed by EMSA as above.
nases, but only ATM-deficiency completely and selec- for this catalytic subunit to appear in the nucleus (Anest
et al., 2003; Yamamoto et al., 2003) raised the possibilitytively blocked NF-B activation by VP16 (Figure 6A, left
images). ATR deficiency had no inhibitory impacts on that a small fraction of nuclear IKK complex might have
mediated NF-B activation in the nucleus. This was aeither of these activation pathways (right images). Sur-
prisingly, in contrast to complete inhibition of NF-B critical issue, since NF-B/IB complexes constitu-
tively shuttle between the cytoplasm and the nucleusactivation, NEMO sumoylation was hardly affected by
ATM deficiency when compared to CHK1-deficiency to afford potential intranuclear activation reactions. We
control (Figure 6B, compare lanes 5 and 6). Importantly, first selectively caused nuclear localization of IB/
ATM-deficiency caused complete loss of NEMO ubiqui- NF-B, but not IB/NF-B, complexes by a brief expo-
tylation (Figure 6C, compare lanes 2 and 4). Thus, these sure to the CRM1 inhibitor leptomycin B (LMB) (Huang
studies revealed a surprising finding that ATM regulated and Miyamoto, 2001) and then examined whether or not
ubiquitylation, but not sumoylation, of NEMO to permit the former were selectively targeted for activation by
the NF-B pathway. Moreover, NEMO became phos- IKK following DNA damage induction. As expected, the
phorylated upon genotoxic stress induction, which was inhibition of nuclear export by LMB did not affect TNF-
prevented by the ATM inhibitor wortmannin (Figures 6D induced activation of IKK (Figure 7A, lane 3). In keeping
and 6E). These results suggested that ATM regulated with the concept that TNF activation of IKK is a cyto-
NEMO phosphorylation and ubiquitylation. plasmic event, TNF caused degradation of cytoplasmic
IB, but not nuclear IB following LMB exposure (Fig-
ure 7B, lane 3, middle and lower images). This resultedActivation of IKK by DNA Damage Is Ultimately
a Cytoplasmic Event in the partial loss of NF-B activation (Figure 7B, lane
3, upper image). Importantly, LMB also did not interfereEven though we did not observe evidence for nuclear
IKK upon genotoxic stress (Figure 3C), the potential with the activation of NEMO-associated IKK by VP16 or
Cell
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Figure 6. ATM Regulates NEMO Ubiquitylation, but Not Sumoylation, Following Genotoxic Stress Induction
(A) HEK293 cells were transfected with either scrambled siRNA (lanes 1–3 and 7–9) or siRNA targeted against ATM (lanes 4–6) or ATR (lanes
10–12). Twenty-four hours after transfection, cells were treated with TNF (10 ng/ml) or VP16 (10 M, lanes 3 and 6; 1 M, lanes 9 and 12)
for 120 min and total cell extracts were prepared and analyzed by EMSA and parallel Western blotting using corresponding antibodies as
shown. Similar effects were seen with siRNA against ATR at 10 M VP16 (data not shown).
(B) HEK293 cells stably expressing Myc-NEMO-WT were cotransfected with a HA-SUMO construct and siRNA against ATM or CHK1, treated
with VP16 (60 min for the upper two images and 120 min for the last four images), and processed for EMSA and Western blot analysis.
(C) HEK293 cells stably expressing Myc-NEMO-WT were transfected with a HA-ubiquitin construct, treated with VP16 for 90 min and processed
for immunoprecipitation and Western blot analysis using HA (upper image) and Myc (lower image) antibodies.
(D) 1.3E2 cells stably expressing Myc-NEMO-WT were labeled with ortho-32P and stimulated with VP16 (20 M, 60 min) in the presence and
absence of wortmannin (20 M), and processed for immunoprecipitation using Myc antibody. Myc-NEMO was transferred to membrane,
exposed to a Phosphorimager screen, and analyzed by ImageQuant (upper image). The membrane was then analyzed by Western blotting
using Myc antibody (lower image).
(E) The intensities of phosphorylated NEMO in D were quantified by ImageQuant from two independent experiments (denoted as • and x) and
displayed as fold-phosphorylation. The data from experiment “x” is shown in (D). The numbers in the parentheses represent the average
values. The reduction of basal phosphorylation of NEMO by wortmannin indicates that stress from ortho-32P labeling likely caused ATM
activation to increase basal phosphorylation of NEMO.
CPT treatment (Figure 7A, lane 6, others not shown), al., 1999). Additionally, TR3, an orphan nuclear receptor,
was shown to rapidly translocate from the nucleus toindicating that the CRM1 export system is not required
for IKK activation by nuclear DNA damage. Moreover, the cytoplasm and finally to mitochondria following ex-
only cytoplasmic IB is inducibly degraded upon expo- posure to apoptosis inducing agents (Li et al., 2000).
sure to VP16 and CPT (Figure 7B, lanes 6 and 9, middle Even though these studies highlighted the existence of
and lower images). This selective degradation of IB molecular communication pathways from the nucleus
again resulted in partial activation of NF-B (Figure 7B, to the cytoplasm, the signaling mechanisms or the na-
lanes 3, 6, and 9, upper image). Collectively, our results ture of the “priming” events remain to be elucidated.
indicated that even though free NEMO was first translo- In the NF-B signaling pathways, NEMO plays an es-
cated to the nucleus in association with SUMO-1 modifi- sential role by permitting physiological regulation of the
cation and then modified by ubiquitylation in an ATM- cytoplasmic IKK complex. However, biochemical events
dependent fashion, the IKK kinase activity that was that are necessary for NEMO to regulate IKK activity
subsequently associated with NEMO was present in the are still unclear. In this study, we delineated sequential
cytoplasm to activate NF-B. regulatory posttranslational modifications of NEMO upon
genotoxic stress induction, which begins with SUMO-1
conjugation. This modification was transient, signal se-Discussion
lective, and not evident with LPS or TNF stimulation.
The signal specificity was in part due to the requirementDespite the vast knowledge accumulating from studies
of the C-terminal ZF domain of NEMO for SUMO-1 modi-focusing on signal transduction pathways emanating
fication. The ZF is required for NF-B activation by DNAfrom cell surface receptors, very little is understood re-
damaging agents, but is dispensable for activation bygarding nuclear-to-cytoplasmic signaling pathways. A
LPS (Huang et al., 2002). We further found that directnuclear “priming” of Ste5, a scaffold for the yeast MAPK
attachment of SUMO-1 to NEMO was sufficient to local-pathway, has been found to be required for activation
of this system from cell surface receptors (Mahanty et ize NEMO to the nucleus and overcome the ZF defi-
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Figure 7. NEMO-Associated and DNA-Damage-Activated IKK is Cytoplasmic
(A) CEM cells were exposed for 60 min to LMB (20 ng/ml, lanes 3, 6, and 7) and unstimulated or stimulated with either TNF (10 ng/ml) for
15 min (lanes 2 and 3) or CPT (10 M) for 60 min (lanes 5 and 6). Protein extracts were then immunoprecipitated with NEMO antibody and
analyzed for phosphorylation of GST-IB (1-66) using -32P-ATP. The kinase reactions were electrophoresed, transferred to membranes,
exposed to Phosphorimager screens, and then analyzed by IKK or GST antibody for loading control.
(B) CEM cells were untreated or pretreated with LMB for 60 min (lanes 3, 6, and 9) and then stimulated with TNF for 30 min (lanes 2 and 3),
or CPT (lanes 5 and 6) or VP16 (10 m; lanes 8 and 9) for 120 min, and processed for EMSA and Western blot analyses using IB and
IB antibodies.
(C) Schematic diagram depicting a model for coordinate regulation of NEMO ubiquitylation by sumoylation and ATM activation following
genotoxic stress induction.
ciency. These studies indicated that the only critical cient to bypass the NF-B activation deficiency of the
NEMO DK mutant. Similar to site-specific competitionfunction of the ZF domain in the context of DNA damage
signaling was to permit sumoylation of NEMO and fur- between sumoylation and ubiquitylation on certain sub-
strates (Desterro et al., 1998; Hoege et al., 2002), ubiqui-ther that the precise location of SUMO-1 did not have
to be at lysine 277 or 309. Similar approaches have been tylation of NEMO was also dependent on intact lysine
277/309. Moreover, the mobility of ubiquitylated NEMOused to study the role of ubiquitin in VP16 transactivation
(Salghetti et al., 2001) and SUMO-1 in Sp3-dependent on SDS-PAGE was faster than that of the sumoylated
one, suggesting ubiquitylated NEMO was devoid oftranscription (Ross et al., 2002). It is interesting to note
that SUMO deconjugation was previously implicated in SUMO-1. Thus, sumoylation is necessary to cause nu-
clear accumulation of NEMO, but it appears to be desu-inhibition of cytokine-induced NF-B activation by the
Yersinia YopJ protein (Orth et al., 2000), but the nature moylated prior to or in conjunction with subsequent
ubiquitylation reaction.of SUMO substrate(s) remains to be determined.
Our data are consistent with the model in which NEMO The role of mutually exclusive modifications of a spe-
cific lysine residue of PCNA by SUMO-1 and ubiquitinis in a dynamic flux between free and IKK-associated
states and that genotoxic stress causes the nuclear has recently been found to play a critical role in DNA
damage repair and DNA replication (Hoege et al., 2002).appearance of free NEMO. The dynamic NEMO associa-
tion with the IKK subunits is consistent with the rapid There are number of DNA damage signaling and repair
proteins that have ubiquitin conjugating or ligase motifs,disruption of the complex by the addition of the NBD
peptide derived from IKK (May et al., 2000). This NBD including RAD6, RAD18, UBC13, UEV1A, BRCA1/BARD1
complex, among others (Abraham, 2001; Kastan andpeptide also did not block the SUMO-1 modification of
NEMO by genotoxic stress, further supporting the notion Lim, 2000; Zhou and Elledge, 2000). It is yet to be deter-
mined how genotoxic stress regulates their enzymaticthat free NEMO is sumoylated. SUMO-1 modification of
NEMO is necessary but insufficient to induce IKK and activity and substrate selectivity. Moreover, it is also
unclear how modification of the same lysine residue(s)NF-B activation since SUMO-1 conjugation was insuffi-
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by SUMO-1 and ubiquitin is enzymatically regulated. NEMO as the, or a component of, DNA damage-induced
Our study provided a surprising observation that ATM nuclear-to-cytoplasmic signal for the NF-B activation
regulates only ubiquitylation, but not sumoylation, in pathway. However, based on immunostaining and bio-
the case of NF-B activation pathway. While ATM was chemical fractionation analyses, we were unable to ob-
implicated in NF-B activation by certain genotoxic serve a large-scale exit of NEMO out of the nucleus prior
stimuli, such as ionizing radiation (Li et al., 2001), the to NF-B activation. This is likely due to a technical issue
manner in which ATM regulates this pathway remained based on the consideration that a fraction of nuclear
mysterious. Our observations together indicated that NEMO may become ubiquitylated and exported out of
genotoxic stress induces two separate signaling path- the nucleus. Consistent with this notion, prevention of
ways to regulate NEMO ubiquitylation (Figure 7C). Coor- NEMO nuclear exit by the attachment of the nuclear
dinate activation of both of these pathways by genotoxic localization signal of SV40 large T antigen prevented
stress—NEMO sumoylation and ATM activation—is NF-B activation when reconstituted in 1.3E2 cells (T.H.,
necessary to permit NEMO ubiquitylation to ultimately unpublished data). There is now emerging evidence that
activate IKK and NF-B. This notion is consistent with IKK activation may involve upstream ubiquitylation of
the observation that attachment of SUMO-1 to NEMO signaling components, such as TRAF2, TRAF6, and
or overexpression of ATM is insufficient for NF-B acti- NEMO, but the precise mechanisms involved have not
vation (Figure 4D and S.M.W.-D, unpublished data). Re- been revealed (Brummelkamp et al., 2003; Deng et al.,
cent studies by Vierstra and colleagues have found that 2000; Kovalenko et al., 2003; Trompouki et al., 2003;
a variety of stresses, such as oxidative stress and heat Wang et al., 2001). It is of great interest to determine
shock, cause transient sumoylation of a multitude of how ubiquitylation of NEMO plays a role in IKK activation
substrates in Arabidopsis (Kurepa et al., 2003). Stress- upon DNA damage induction.
dependent sumoylation of different substrates has also Since NF-B has emerged as a key determinant for
been observed in mammalian cells (Hietakangas et al., cellular sensitivity to anticancer drugs and radiation
2003; Mao et al., 2000; Rodriguez et al., 1999; Rui et al., treatments (Karin et al., 2002), the sequential posttrans-
2002). Thus, it is probable that transient SUMO modifica- lational modifications of NEMO by SUMO-1 and ubiqui-
tion of NEMO by genotoxic stress is due to a stress- tin may also provide pathway-selective targets to en-
signaling pathway unrelated to DNA damage per se. hance anticancer therapy. Our important future goals
In contrast, NEMO ubiquitylation seems to require a include the identification of molecular components and
separate signaling pathway from DNA double-strand their regulatory mechanisms involved in these modifica-
break to ATM activation. Moreover, NEMO is phosphory- tions of NEMO in the NF-B genotoxic signal transduc-
lated upon DNA damage induction in vivo that is com- tion pathway to identify relevant targets for cancer
pletely inhibited by an ATM inhibitor. ATM siRNA did treatment.
not increase the detection of steady-state levels of su-
moylated NEMO following genotoxic stress. This sug- Experimental Procedures
gested that ATM was not required for desumoylation;
Plasmidsotherwise, the accumulation of sumoylated NEMO
Myc-NEMO was described previously (Huang et al., 2002). Genera-would be expected without ATM. Kinetics of NF-B acti-
tion of point mutations of NEMO at lysines 277 and/or 309 to alaninesvation by genotoxic stress was transient, like sumoyla-
or arginines were done by two-step PCR mutagenesis from the
tion. However, ATM activation is documented to be very original NEMO template and verified by DNA sequencing. To gener-
prompt and persistent following DNA damage induction ate HA-tagged SUMO-1-NEMO fusion constructs, SUMO-1 (amino
(Bakkenist and Kastan, 2003). When SUMO-NEMO fu- acids 1–96) was amplified by PCR and cloned into the 2 HA
sion was supplied constitutively to overcome the neces- pcDNA3 vector (Invitrogen). NEMO was then amplified by PCR and
cloned downstream of SUMO-1 in frame.sity of sumoylation, NF-B activation reached the maxi-
mal level faster and persisted much longer. Thus, one
Reagents and Antibodiescan modulate the time course of NF-B activation by
VP16, CPT and bacterial LPS were purchased from Sigma and hu-genotoxic stress conditions by bypassing the major
man recombinant TNF was from Calbiochem. IgGs against IKKrate-limiting SUMO step. Identification of NEMO phos- (M280), c-Myc (9E10), NEMO (M-18), IB (C-21), p65 (C-20), DNA-
phorylation site(s), and specific ubiquitin E2 and E3, PK (C-19), CHK1 (Fl-476), CHK2 (H-300), and GST (B-14) were pur-
along with specific SUMO E3 and hydrolase, will be chased from Santa Cruz Biotechnology. Anti-SUMO-1 (anti-GMP1)
required to determine how sumoylation and ATM activa- was from Zymed Laboratories, anti-Flag (M2) was from Sigma, anti-
HA.11 and antiubiquitin were from Covance, and anti-ATM (2C1)tion coordinate NEMO ubiquitylation following geno-
was from GeneTex. Anti-ATR polyclonal rabbit IgG was a gift fromtoxic stress. These studies may also help link the above
Dr. R. Tibbetts (Tibbetts et al., 2000). Antirabbit and antimouse anti-NEMO modifications with the RIP kinase that was re-
bodies and Protein-A, each conjugated to horseradish peroxidase,
cently implicated in a genotoxic stress-dependent activa- were obtained from Amersham Pharmacia Biotech. The cell perme-
tion of NF-B (Hur et al., 2003). These studies may also able NBD peptide (May et al., 2000) was purchased from BIOMOL.
help sort out different conflicting events implicated in Cell and extract preparations for EMSA and Western blot analyses
NF-B activation by genotoxic agents (Criswell et al., were described previously (Huang et al., 2000a). Cytoplasmic and
nuclear extracts from HEK293 cells were prepared as described2003) into those induced by DNA damage per se and
previously (Miyamoto et al., 1998). SiRNA-mediated interference tothose related to other stresses induced by these agents
downregulate ATM, ATR, or Chk1 expression in HEK293 cells (35without involving damage to the DNA.
mm dishes) was done by transfecting 200 pmoles each of
While SUMO-1 modification is involved in nuclear lo- SMARTpool double-stranded RNA oligonucleotides (Dharmacon) or
calization of NEMO and subsequent ubiquitylation, the scramble siRNA ( strand, 5	-AAUACCGUCUCCACUUGAUCGdTdT-
ultimate IKK and NF-B activation was found to be cyto- 3	; 
 strand, 5	-CGAUCAAGUGGAGACGGUAdTdT-3	) using a cal-
cium-phosphate method as previously described (Huang et al., 2000a).plasmic. The simplest interpretation is to consider free
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Cell Culture and Generation of Stable Transfectants (2003). Loss of the cylindromatosis tumour suppressor inhibits apo-
ptosis by activating NF-B. Nature 424, 797–801.1.3E2 murine pre-B and its derivatives, Cos7, HEK293, and CEM cells
were grown as described previously (Huang et al., 2002). Transient Criswell, T., Leskov, K., Miyamoto, S., Luo, G., and Boothman, D.A.
transfection of plasmid DNA in HEK293 or Cos-7 cells was done using (2003). Transcription factors activated in mammalian cells after clini-
standard calcium phosphate precipitation method (Huang et al., cally relevant doses of ionizing radiation. Oncogene 22, 5813–5827.
2000a). 1.3E2 cells were reconstituted with Myc- or HA-tagged NEMO
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaugh-
WT or mutants by electroporation and selection with G418 (1 mg/ml)
ter, C., Pickart, C., and Chen, Z.J. (2000). Activation of the IB kinase
as described previously (Huang et al., 2002).
complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme
complex and a unique polyubiquitin chain. Cell 103, 351–361.
Kinase Assay and Immunoprecipitation
Desterro, J.M., Rodriguez, M.S., and Hay, R.T. (1998). SUMO-1 modi-The IKK kinase assay was described previously (Huang et al., 2002).
fication of IB inhibits NF-B activation. Mol. Cell 2, 233–239.Samples for IP experiments were done as described above except for
Devary, Y., Gottlieb, R.A., Smeal, T., and Karin, M. (1992). The mam-immediate boiling in 1% SDS for 15 min followed by dilution with the
malian ultraviolet response is triggered by activation of Src tyrosineIP buffer to 0.1% SDS prior to immunoprecipitation.
kinases. Cell 71, 1081–1091.
Doffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J.,Immunostaining
Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche,1.3E2 pre-B and Cos7 cell lines were cultured in four-well chamber
S., et al. (2001). X-linked anhidrotic ectodermal dysplasia with immu-slides (LAB-TEK II CC2 treated or LAB-TEK), stimulated, and then
nodeficiency is caused by impaired NF-B signaling. Nat. Genet.processed as described previously (Huang et al., 2002) using appro-
27, 277–285.priate primary antibodies (1:250). DNA was visualized by Hoechst
33342 (Molecular Probes) staining. Cells were mounted with Prolong Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-B puzzle.
Antifade (Molecular Probes), visualized, and photographed using a Cell 109 (Suppl), S81–S96.
Zeiss Axioplan epifluorescence microscope with the aid of fluorescein Hietakangas, V., Ahlskog, J.K., Jakobsson, A.M., Hellesuo, M., Sahl-
or rhodamine-specific filters. berg, N.M., Holmberg, C.I., Mikhailov, A., Palvimo, J.J., Pirkkala, L.,
and Sistonen, L. (2003). Phosphorylation of serine 303 is a prerequi-
In Vivo Ortho-32P Labeling of NEMO site for the stress-inducible SUMO modification of heat shock factor
1  107 1.3E2 cells stably expressing Myc-NEMO-WT were incubated 1. Mol. Cell. Biol. 23, 2953–2968.
for 2 hr at 37C under 10% C02 with 1.5 mCi of sodium ortho-32P (ICN Hoege, C., Pfander, B., Moldovan, G.L., Pyrowolakis, G., andPharmaceutical, Inc.) in 1 ml of phosphate-free DMEM in the presence
Jentsch, S. (2002). RAD6-dependent DNA repair is linked to modifi-of 10% fetal calf serum previously dialyzed against excess Tris-buf-
cation of PCNA by ubiquitin and SUMO. Nature 419, 135–141.fered saline. Cells were then stimulated for 60 min, washed with ice-
Huang, T.T., and Miyamoto, S. (2001). Postrepression activation ofcold PBS, lysed in 1% SDS in the IP buffer above containing protease
NF-B requires the amino-terminal nuclear export signal specific toinhibitors and phosphatase inhibitors as described (Huang et al., 2002),
IB. Mol. Cell. Biol. 21, 4737–4747.boiled for 10 min, and then processed for immunoprecipitation as
above. Myc-NEMO was released by boiling and reimmunoprecipitated Huang, T.T., Wuerzberger-Davis, S.M., Seufzer, B.J., Shumway,
to reduce background signals. Final immunoprecipitates were trans- S.D., Kurama, T., Boothman, D.A., and Miyamoto, S. (2000a). NF-B
ferred to Immobilon-P membrane following 10% SDS-PAGE, exposed activation by camptothecin: a linkage between nuclear DNA damage
to a Phosphorimager screen, and analyzed by the ImageQuant pro- and cytoplasmic signaling events. J. Biol. Chem. 275, 9501–9509.
gram. The membranes were then processed for Western blot analysis Huang, T.T., Kudo, N., Yoshida, M., and Miyamoto, S. (2000b). A
with an anti-Myc-antibody to ensure equivalent IP efficiency. nuclear export signal in the N-terminal regulatory doman of IBa
controls cytoplasmic localization of the inactive NF-B/IBa com-
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